Source: Zacks

Dr.Reddy's: RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

Dr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.

Read full article »
Annual Revenue
$1.0-5.0B
Employees
10-50K
Erez Israeli's photo - CEO of Dr.Reddy's

CEO

Erez Israeli

CEO Approval Rating

67/100

Read more